This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

MRCP (magnetic resonance cholangiopancreatography)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Magnetic resonance cholangiopancreatography (MRCP) is

  • imaging technique used for noninvasive work-up of patients with pancreaticobiliary disease
  • magnetic resonance cholangiopancreatography is useful in the evaluation of a host of pancreaticobiliary disorders, such as congenital disorders, calculus disease, biliary strictures, sclerosing cholangitis, chronic pancreatitis, and cystic pancreatic lesions
  • provides useful preoperative information to surgeons and gastroenterologists
  • serves as a valuable tool in the assessment of postoperative pancreaticobiliary ductal anatomy

NICE state to (1):

Consider magnetic resonance cholangiopancreatography (MRCP) if ultrasound has not detected common bile duct stones but the:

  • bile duct is dilated and/or
  • liver function test results are abnormal

Consider endoscopic ultrasound (EUS) if MRCP does not allow a diagnosis to be made.

Refer people for further investigations if conditions other than gallstone disease are suspected

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.